PMC Articles for MedGen (Select 208958) - PMC

Links from MedGen

Items: 1 to 20 of 102

<< First< Prev

Page of 6

Select item 37886001.

Specific features identify patients with relapsed/refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation

Ryan D. Cassaday, Katherine A. Guthrie, Elizabeth L. Budde, Leslie Thompson, Brian G. Till, Oliver W. Press, Thomas R. Chauncey, John M. Pagel, Steven H. Petersdorf, Maria Corinna Palanca-Wessels, Mary Philip, William I. Bensinger, Leona A. Holmberg, Andrei Shustov, Damian J. Green, Edward N. Libby, David G. Maloney, Ajay K. Gopal

Biol Blood Marrow Transplant. Author manuscript; available in PMC 2014 Sep 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2013 Sep; 19(9): 1403–1406. Published online 2013 Jul 17. doi: 10.1016/j.bbmt.2013.07.005

PMCID:: PMC3788600

Abstract Article PDF–128K

Select item 73519902.

Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date

Yazeed Sawalha, David A Bond, Lapo Alinari

Onco Targets Ther. 2020; 13: 6573–6581. Published online 2020 Jul 6. doi: 10.2147/OTT.S238832

Correction in:: Onco Targets Ther. 2020; 13: 8009.

PMCID:: PMC7351990

Abstract Article PDF–1.0M

Select item 73770083.

Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell Lymphoma

Clifford B Locke, Jr., Frederick Lansigan

Cureus. 2020 Jun; 12(6): e8743. Published online 2020 Jun 21. doi: 10.7759/cureus.8743

PMCID:: PMC7377008

Abstract Article PDF–524K

Select item 74807464.

Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]

Onco Targets Ther. 2020; 13: 8009. Published online 2020 Sep 4. doi: 10.2147/OTT.S278185

Corrects:: Onco Targets Ther. 2020; 13: 6573–6581.

PMCID:: PMC7480746

Correction PDF–159K

Select item 40319055.

Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective

Madhav Desai, Kate Newberry, Zhishuo Ou, Michael Wang, Liang Zhang

Ther Adv Hematol. 2014 Jun; 5(3): 91–101. doi: 10.1177/2040620714532124

PMCID:: PMC4031905

Abstract Article PDF–729K

Select item 77016656.

Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy

Chunmei Yang, Wen Lei, Hongqiong Xie, Gongqiang Wu, Juying Wei, Aibin Liang, Wenbin Qian

Onco Targets Ther. 2020; 13: 12163–12168. Published online 2020 Nov 25. doi: 10.2147/OTT.S280535

PMCID:: PMC7701665

Abstract Article PDF–1.9M

Select item 77314417.

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Javier Munoz, Andre Goy, Frederick L. Locke, Caron A. Jacobson, Brian T. Hill, John M. Timmerman, Houston Holmes, Samantha Jaglowski, Ian W. Flinn, Peter A. McSweeney, David B. Miklos, John M. Pagel, Marie José Kersten, Noel Milpied, Henry Fung, Max S. Topp, Roch Houot, Amer Beitinjaneh, Weimin Peng, Lianqing Zheng, John M. Rossi, Rajul K. Jain, Arati V. Rao, Patrick M. Reagan

N Engl J Med. Author manuscript; available in PMC 2020 Dec 11.

Published in final edited form as: N Engl J Med. 2020 Apr 2; 382(14): 1331–1342. doi: 10.1056/NEJMoa1914347

PMCID:: PMC7731441

Abstract Article PDF–770K

Select item 78643748.

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang, Simon Rule, Pier Luigi Zinzani, Andre Goy, Olivier Casasnovas, Stephen D Smith, Gandhi Damaj, Jeanette Doorduijn, Thierry Lamy, Franck Morschhauser, Carlos Panizo, Bijal Shah, Andrew Davies, Richard Eek, Jehan Dupuis, Eric Jacobsen, Arnon P Kater, Steven Le Gouill, Lucie Oberic, Taduesz Robak, Todd Covey, Richa Dua, Ahmed Hamdy, Xin Huang, Raquel Izumi, Priti Patel, Wayne Rothbaum, J Greg Slatter, Wojciech Jurczak

Lancet. Author manuscript; available in PMC 2021 Feb 5.

Published in final edited form as: Lancet. 2018 Feb 17; 391(10121): 659–667. Published online 2017 Dec 11. doi: 10.1016/S0140-6736(17)33108-2

PMCID:: PMC7864374

Abstract Article PDF–1006K

Select item 38119059.

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study

P. L. Zinzani, J. M. Vose, M. S. Czuczman, C. B. Reeder, C. Haioun, J. Polikoff, H. Tilly, L. Zhang, K. Prandi, J. Li, T. E. Witzig

Ann Oncol. 2013 Nov; 24(11): 2892–2897. Published online 2013 Sep 12. doi: 10.1093/annonc/mdt366

PMCID:: PMC3811905

Abstract Article PDF–131K

Select item 709911110.

Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L

Michael Herdman, Cicely Kerr, Marco Pavesi, Jamie Garside, Andrew Lloyd, Patricia Cubi-Molla, Nancy Devlin

J Patient Rep Outcomes. 2020 Dec; 4: 22. Published online 2020 Mar 27. doi: 10.1186/s41687-020-0185-3

PMCID:: PMC7099111

Abstract Article PDF–1010K

Select item 812887411.

Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Yang Liu, Qingsong Cai, Rongjia Zhang, Joseph McIntosh, Ruiping Wang, Minghao Dang, Enyu Dai, Yuanxin Wang, David Santos, Maria Badillo, Angela Leeming, Zhihong Chen, Kimberly Hartig, John Bigcal, Jia Zhou, Rashmi Kanagal-Shamanna, Chi Young Ok, Hun Lee, Raphael E. Steiner, Jianhua Zhang, Xingzhi Song, Ranjit Nair, Sairah Ahmed, Alma Rodriquez, Selvi Thirumurthi, Preetesh Jain, Nicolaus Wagner-Bartak, Holly Hill, Krystle Nomie, Christopher Flowers, Andrew Futreal, Linghua Wang, Michael Wang

Nat Commun. 2021; 12: 2877. Published online 2021 May 17. doi: 10.1038/s41467-021-22872-z

Correction in:: Nat Commun. 2024; 15: 8668.

PMCID:: PMC8128874

Abstract Article PDF–6.0M

Select item 339668212.

A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma

Christoph Renner, Pier Luigi Zinzani, Rémy Gressin, Dirk Klingbiel, Pierre-Yves Dietrich, Felicitas Hitz, Mario Bargetzi, Walter Mingrone, Giovanni Martinelli, Andreas Trojan, Krimo Bouabdallah, Andreas Lohri, Emmanuel Gyan, Christine Biaggi, Sergio Cogliatti, Francesco Bertoni, Michele Ghielmini, Peter Brauchli, Nicolas Ketterer

Haematologica. 2012 Jul; 97(7): 1085–1091. doi: 10.3324/haematol.2011.053173

PMCID:: PMC3396682

Abstract Article PDF–705K

Select item 330624513.

Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?

Sebastian Kirschey, Susanne Wagner, Georg Hess

Clin Med Insights Oncol. 2012; 6: 153–164. Published online 2012 Mar 12. doi: 10.4137/CMO.S7327

PMCID:: PMC3306245

Abstract Article PDF–997K

Select item 827066314.

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Constantine S. Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Tycel J. Phillips, Won Seog Kim, Simon Rule, Siminder Kaur Atwal, Rachel Wei, William Novotny, Jane Huang, Michael Wang, Judith Trotman

Blood Adv. 2021 Jun 22; 5(12): 2577–2585. Published online 2021 Jun 21. doi: 10.1182/bloodadvances.2020004074

PMCID:: PMC8270663

Abstract Article PDF–784K

Select item 842580215.

Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma

Jing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, Ya Hwee Tan, Valerie Shiwen Yang, Esther Wei Yin Chang, Eileen Poon, Nagavalli Somasundaram, Mohamad Farid, Miriam Tao, Soon Thye Lim, Jason Yongsheng Chan

J Hematol. 2021 Aug; 10(4): 187–195. Published online 2021 Aug 30. doi: 10.14740/jh890

PMCID:: PMC8425802

Abstract Article PDF–1.4M

Select item 851815316.

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials

Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Zhiyue Huang, Huafei Lu, Yuqin Song, Yongping Song

J Hematol Oncol. 2021; 14: 167. Published online 2021 Oct 14. doi: 10.1186/s13045-021-01174-3

PMCID:: PMC8518153

Abstract Article PDF–663K

Select item 855697517.

Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study

Michael Wang, Radhakrishnan Ramchandren, Robert Chen, Lionel Karlin, Geoffrey Chong, Wojciech Jurczak, Ka Lung Wu, Mark Bishton, Graham P. Collins, Paul Eliadis, Frédéric Peyrade, Yihua Lee, Karl Eckert, Jutta K. Neuenburg, Constantine S. Tam

J Hematol Oncol. 2021; 14: 179. Published online 2021 Oct 30. doi: 10.1186/s13045-021-01188-x

PMCID:: PMC8556975

Abstract Article PDF–1.0M

Select item 329159718.

Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers

Francesco Zaja, Stefano De Luca, Umberto Vitolo, Lorella Orsucci, Alessandro Levis, Flavia Salvi, Chiara Rusconi, Erika Ravelli, Alessandra Tucci, Chiara Bottelli, Monica Balzarotti, Ercole Brusamolino, Maurizio Bonfichi, Stefano A. Pileri, Elena Sabattini, Stefano Volpetti, Chiara Monagheddu, Angelo Vacca, Roberto Ria, Renato Fanin

Haematologica. 2012 Mar; 97(3): 416–422. doi: 10.3324/haematol.2011.051813

PMCID:: PMC3291597

Abstract Article PDF–326K

Select item 448430019.

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin Dependent Kinase Inhibitor, in Patients with Relapsed or Refractory Mantle Cell Lymphoma

Ryan D. Cassaday, Andre Goy, Suresh Advani, Purvi Chawla, Rajesh Nachankar, Mansi Gandhi, Ajay K. Gopal

Clin Lymphoma Myeloma Leuk. Author manuscript; available in PMC 2016 Jul 1.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2015 Jul; 15(7): 392–397. Published online 2015 Mar 5. doi: 10.1016/j.clml.2015.02.021

PMCID:: PMC4484300

Abstract Article PDF–258K

Select item 493553020.

Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Analysis in the Rituximab Era

Alberto Mussetti, Sean M. Devlin, Hugo R Castro-Malaspina, Juliet N. Barker, Sergio A. Giralt, Andrew D. Zelenetz, Craig S. Sauter, Miguel-Angel Perales

Bone Marrow Transplant. Author manuscript; available in PMC 2016 Jul 6.

Published in final edited form as: Bone Marrow Transplant. 2015 Oct; 50(10): 1293–1298. Published online 2015 Jul 6. doi: 10.1038/bmt.2015.156

PMCID:: PMC4935530

Abstract Article PDF–559K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 102

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity